Senate Introduced Bill
Introduced bills appear as they were introduced and reflect no subsequent amendments or changes
Senate Bill 578 of 2021
Sponsors
- Winnie Brinks (District 29)
- Sean McCann (District 20)
- Marshall Bullock II (District 4)
- Dayna Polehanki (District 7)
- Stephanie Chang (District 1)
- Jeff Irwin (District 18)
- Rosemary Bayer (District 12)
- Paul Wojno (District 9)
- Sylvia Santana (District 3)
- Curtis VanderWall (District 35)
- Mallory McMorrow (District 13)
- Jeremy Moss (District 11)
- Betty Jean Alexander (District 5)
- Jim Ananich (District 27)
- Erika Geiss (District 6)
- Rick Outman (District 33)
- Lana Theis (District 22)
- Adam Hollier (District 2)
- Curtis Hertel, Jr. (District 23)
Categories
Controlled substances: opioids; Health: pharmaceuticals; State agencies (existing): licensing and regulatory affairs; State agencies (existing): health and human services
Controlled substances: opioids; distribution of opioid antagonists by community-based organizations under a standing order; allow. Amends sec. 17744e of 1978 PA 368 (MCL 333.17744e).
Documents
Analysis
Senate Fiscal Agency Analysis
History
(House actions in lowercase, Senate actions in UPPERCASE)Note: A page number of 0 indicates that the page number is coming soon
Date | Journal | Action |
---|---|---|
6/30/2021 | SJ 60 Pg. 1082 | INTRODUCED BY SENATOR WINNIE BRINKS |
6/30/2021 | SJ 60 Pg. 1082 | REFERRED TO COMMITTEE ON HEALTH POLICY AND HUMAN SERVICES |
10/12/2021 | SJ 79 Pg. 1700 | REPORTED FAVORABLY WITHOUT AMENDMENT |
10/12/2021 | SJ 79 Pg. 1700 | COMMITTEE RECOMMENDED IMMEDIATE EFFECT |
10/12/2021 | SJ 79 Pg. 1700 | REFERRED TO COMMITTEE OF THE WHOLE |
10/13/2021 | SJ 80 Pg. 1711 | REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITHOUT AMENDMENT(S) |
10/13/2021 | SJ 80 Pg. 1711 | PLACED ON ORDER OF THIRD READING |
10/14/2021 | SJ 81 Pg. 1719 | PASSED ROLL CALL # 383 YEAS 35 NAYS 0 EXCUSED 1 NOT VOTING 0 |
10/14/2021 | HJ 84 Pg. 1916 | received on 10/14/2021 |
10/14/2021 | HJ 84 Pg. 1918 | read a first time |
10/14/2021 | HJ 84 Pg. 1918 | referred to Committee on Health Policy |
6/30/2022 | HJ 63 Pg. 1017 | reported with recommendation without amendment |
6/30/2022 | HJ 63 Pg. 1017 | referred to second reading |